- Feature Paper
- Article
Evaluation of the TruSight Tumor 170 Assay and Its Value in Clinical Diagnostics
- Carina Heydt,
- Roberto Pappesch,
- Katrin Stecker,
- Martin März and
- Sabine Merkelbach-Bruse
Background: Parallel sequencing technologies have become integrated into clinical practice. This study evaluated the TruSight Tumor 170 assay for the simultaneous detection of somatic gene mutations (SNPs and indels), gene fusions and CNVs, and its i...

